Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


Articles published in Psychol Med

Retrieve available abstracts of 120 articles:
HTML format
Text format



Single Articles


    April 2017
  1. OUELLET-PLAMONDON C, Abdel-Baki A, Salvat E, Potvin S, et al
    Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes.
    Psychol Med. 2017 Apr 20:1-11. doi: 10.1017/S0033291717000976.
    PubMed     Text format     Abstract available


  2. VERMEULEN J, van Rooijen G, Doedens P, Numminen E, et al
    Antipsychotic medication and long-term mortality risk in patients with schizophrenia; a systematic review and meta-analysis.
    Psychol Med. 2017 Apr 11:1-12. doi: 10.1017/S0033291717000873.
    PubMed     Text format     Abstract available


  3. DEMJAHA A, Lappin JM, Stahl D, Patel MX, et al
    Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.
    Psychol Med. 2017 Apr 11:1-9. doi: 10.1017/S0033291717000435.
    PubMed     Text format     Abstract available


  4. KNAPP F, Viechtbauer W, Leonhart R, Nitschke K, et al
    Planning performance in schizophrenia patients: a meta-analysis of the influence of task difficulty and clinical and sociodemographic variables.
    Psychol Med. 2017 Apr 7:1-15. doi: 10.1017/S0033291717000459.
    PubMed     Text format     Abstract available


  5. CHIEN WT, Bressington D, Yip A, Karatzias T, et al
    An international multi-site, randomized controlled trial of a mindfulness-based psychoeducation group programme for people with schizophrenia.
    Psychol Med. 2017 Apr 4:1-16. doi: 10.1017/S0033291717000526.
    PubMed     Text format     Abstract available


    March 2017
  6. EMSLEY R, Asmal L, du Plessis S, Chiliza B, et al
    Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
    Psychol Med. 2017 Mar 28:1-10. doi: 10.1017/S0033291717000642.
    PubMed     Text format     Abstract available


  7. BRUCATO G, Masucci MD, Arndt LY, Ben-David S, et al
    Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.
    Psychol Med. 2017 Mar 2:1-13. doi: 10.1017/S0033291717000319.
    PubMed     Text format     Abstract available


    February 2017
  8. VAN RHEENEN TE, Lewandowski KE, Tan EJ, Ospina LH, et al
    Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum.
    Psychol Med. 2017 Feb 28:1-17. doi: 10.1017/S0033291717000307.
    PubMed     Text format     Abstract available


  9. FIRTH J, Stubbs B, Sarris J, Rosenbaum S, et al
    The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2017 Feb 16:1-13. doi: 10.1017/S0033291717000022.
    PubMed     Text format     Abstract available


  10. GRONHOLM PC, Thornicroft G, Laurens KR, Evans-Lacko S, et al
    Mental health-related stigma and pathways to care for people at risk of psychotic disorders or experiencing first-episode psychosis: a systematic review.
    Psychol Med. 2017 Feb 15:1-13. doi: 10.1017/S0033291717000344.
    PubMed     Text format     Abstract available


  11. RHINDRESS K, Robinson DG, Gallego JA, Wellington R, et al
    Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.
    Psychol Med. 2017 Feb 14:1-13. doi: 10.1017/S0033291717000137.
    PubMed     Text format     Abstract available


  12. XU Y, Qin W, Zhuo C, Xu L, et al
    Selective functional disconnection of the orbitofrontal subregions in schizophrenia.
    Psychol Med. 2017 Feb 10:1-10. doi: 10.1017/S0033291717000101.
    PubMed     Text format     Abstract available


  13. NIELSEN SM, Toftdahl NG, Nordentoft M, Hjorthoj C, et al
    Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study.
    Psychol Med. 2017 Feb 7:1-10. doi: 10.1017/S0033291717000162.
    PubMed     Text format     Abstract available


  14. OCHOA S, Lopez-Carrilero R, Barrigon ML, Pousa E, et al
    Randomized control trial to assess the efficacy of metacognitive training compared with a psycho-educational group in people with a recent-onset psychosis.
    Psychol Med. 2017 Feb 7:1-12. doi: 10.1017/S0033291716003421.
    PubMed     Text format     Abstract available


    January 2017
  15. STONE J, Koychev I, Reilly T, McGuire P, et al
    Reply to: Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Psychol Med. 2017 Jan 23:1. doi: 10.1017/S0033291716003470.
    PubMed     Text format    


  16. WOOLLEY JD, Chuang B, Fussell C, Scherer S, et al
    Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls.
    Psychol Med. 2017 Jan 16:1-12. doi: 10.1017/S0033291716003433.
    PubMed     Text format     Abstract available


  17. STUDERUS E, Ramyead A, Riecher-Rossler A
    Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting.
    Psychol Med. 2017 Jan 16:1-16. doi: 10.1017/S0033291716003494.
    PubMed     Text format     Abstract available


  18. IWABUCHI SJ, Palaniyappan L
    Abnormalities in the effective connectivity of visuothalamic circuitry in schizophrenia.
    Psychol Med. 2017 Jan 12:1-11. doi: 10.1017/S0033291716003469.
    PubMed     Text format     Abstract available


    December 2016
  19. BORA E, Akdede BB, Alptekin K
    The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis.
    Psychol Med. 2016 Dec 29:1-11. doi: 10.1017/S0033291716003366.
    PubMed     Text format     Abstract available


  20. LIU M, Malone SM, Vaidyanathan U, Keller MC, et al
    Psychophysiological endophenotypes to characterize mechanisms of known schizophrenia genetic loci.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  21. MAIA-DE-OLIVEIRA JP, Baker GB, Dursun SM, Hallak JE, et al
    Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?
    Psychol Med. 2016.
    PubMed     Text format    


  22. GAGE SH, Jones HJ, Burgess S, Bowden J, et al
    Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  23. STILO SA, Gayer-Anderson C, Beards S, Hubbard K, et al
    Further evidence of a cumulative effect of social disadvantage on risk of psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    November 2016
  24. WU C, Zheng Y, Li J, Wu H, et al
    Brain substrates underlying auditory speech priming in healthy listeners and listeners with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  25. RAPADO-CASTRO M, Dodd S, Bush AI, Malhi GS, et al
    Cognitive effects of adjunctive N-acetyl cysteine in psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  26. CHANG WC, Kwong VW, Hui CL, Chan SK, et al
    Relationship of amotivation to neurocognition, self-efficacy and functioning in first-episode psychosis: a structural equation modeling approach.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  27. KLAAS HS, Clemence A, Marion-Veyron R, Antonietti JP, et al
    Insight as a social identity process in the evolution of psychosocial functioning in the early phase of psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  28. LANGE EH, Nerland S, Jorgensen KN, Morch-Johnsen L, et al
    Alcohol use is associated with thinner cerebral cortex and larger ventricles in schizophrenia, bipolar disorder and healthy controls.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  29. MCHUGH MJ, McGorry PD, Yung AR, Lin A, et al
    Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    October 2016
  30. RYDKJAER J, Mollegaard Jepsen JR, Pagsberg AK, Fagerlund B, et al
    Mismatch negativity and P3a amplitude in young adolescents with first-episode psychosis: a comparison with ADHD.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  31. SHAH C, Zhang W, Xiao Y, Yao L, et al
    Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  32. RIKANDI E, Pamilo S, Mantyla T, Suvisaari J, et al
    Precuneus functioning differentiates first-episode psychosis patients during the fantasy movie Alice in Wonderland.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  33. VEERMAN SR, Schulte PF, Deijen JB, de Haan L, et al
    Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  34. PRUESSNER M, Bechard-Evans L, Pira S, Joober R, et al
    Interplay of hippocampal volume and hypothalamus-pituitary-adrenal axis function as markers of stress vulnerability in men at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  35. SCHMIDT A, Antoniades M, Allen P, Egerton A, et al
    Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  36. ROCCA P, Galderisi S, Rossi A, Bertolino A, et al
    Social cognition in people with schizophrenia: a cluster-analytic approach.
    Psychol Med. 2016;46:2717-29.
    PubMed     Text format     Abstract available


    September 2016
  37. STONE JM, Morrison PD, Koychev I, Gao F, et al
    The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  38. STEEL C, Hardy A, Smith B, Wykes T, et al
    Cognitive-behaviour therapy for post-traumatic stress in schizophrenia. A randomized controlled trial.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  39. FRAJO-APOR B, Kemmler G, Pardeller S, Plass T, et al
    Emotional intelligence and non-social cognition in schizophrenia and bipolar I disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  40. VELING W, Counotte J, Pot-Kolder R, van Os J, et al
    Childhood trauma, psychosis liability and social stress reactivity: a virtual reality study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  41. LALLY J, Ajnakina O, Di Forti M, Trotta A, et al
    Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  42. FISZDON JM, Choi KH, Bell MD, Choi J, et al
    Cognitive remediation for individuals with psychosis: efficacy and mechanisms of treatment effects.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  43. CHEN DC, Du XD, Yin GZ, Yang KB, et al
    Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  44. O'REILLY K, O'Connell P, Donohoe G, Coyle C, et al
    Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  45. RINGEN PA, Nesvag R, Helle S, Lagerberg TV, et al
    Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  46. HODGINS S, Larm P, Westerman J
    Individuals developing schizophrenia are hidden among adolescent substance misusers.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  47. PERALTA V, Cuesta MJ
    Delusional disorder and schizophrenia: a comparative study across multiple domains.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  48. RENTZSCH J, Koller K, Kronenberg G
    Letter to the Editor: Disentangling cause and effect in the relationship between cannabis and psychosis: are we there yet?
    Psychol Med. 2016.
    PubMed     Text format    


  49. MIKOLAS P, Melicher T, Skoch A, Matejka M, et al
    Connectivity of the anterior insula differentiates participants with first-episode schizophrenia spectrum disorders from controls: a machine-learning study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  50. RIMVALL MK, Clemmensen L, Munkholm A, Rask CU, et al
    Introducing the White Noise task in childhood: associations between speech illusions and psychosis vulnerability.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  51. REININGHAUS U, Gayer-Anderson C, Valmaggia L, Kempton MJ, et al
    Psychological processes underlying the association between childhood trauma and psychosis in daily life: an experience sampling study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  52. WANG C, Ji F, Hong Z, Poh JS, et al
    Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  53. FINEBERG SK, Leavitt J, Deutsch-Link S, Dealy S, et al
    Self-reference in psychosis and depression: a language marker of illness.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  54. HU M, Zong X, Zheng J, Mann JJ, et al
    Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  55. HUI CL, Li YK, Li AW, Lee EH, et al
    Visual working memory deterioration preceding relapse in psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  56. DE BONT PA, van den Berg DP, van der Vleugel BM, de Roos C, et al
    Prolonged exposure and EMDR for PTSD v. a PTSD waiting-list condition: effects on symptoms of psychosis, depression and social functioning in patients with chronic psychotic disorders.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  57. BERGINK V, Laursen TM, Johannsen BM, Kushner SA, et al
    Letter to the Editor: Postpartum psychosis and pre-eclamptic toxaemia: a reply.
    Psychol Med. 2016.
    PubMed     Text format    


  58. CHEN LJ, Steptoe A, Chung MS, Ku PW, et al
    Association between actigraphy-derived physical activity and cognitive performance in patients with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  59. BROCKINGTON I
    Letter to the Editor Postpartum psychosis and pre-eclamptic toxaemia.
    Psychol Med. 2016.
    PubMed     Text format    


  60. JUNG E, Wiesjahn M, Wendt H, Bock T, et al
    Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  61. HARING L, Muursepp A, Mottus R, Ilves P, et al
    Cortical thickness and surface area correlates with cognitive dysfunction among first-episode psychosis patients.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    May 2016
  62. GUO S, Palaniyappan L, Liddle PF, Feng J, et al
    Dynamic cerebral reorganization in the pathophysiology of schizophrenia: a MRI-derived cortical thickness study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  63. BAKKER G, Caan MW, Schluter RS, Bloemen OJ, et al
    Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  64. LEE EH, Hui CL, Chang WC, Chan SK, et al
    Letter to the Editor: Comparison of cognitive functions, pre-morbid conditions and clinical characteristics between brief psychotic disorder and schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format    


  65. O'DONOGHUE B, Lyne JP, Renwick L, Lane A, et al
    Neighbourhood characteristics and the incidence of first-episode psychosis and duration of untreated psychosis.
    Psychol Med. 2016;46:1367-78.
    PubMed     Text format     Abstract available


    April 2016
  66. CABRERA B, Bioque M, Penades R, Gonzalez-Pinto A, et al
    Cognition and psychopathology in first-episode psychosis: are they related to inflammation?
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  67. KIMHY D, Gill KE, Brucato G, Vakhrusheva J, et al
    The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  68. JORGENSEN KN, Nerland S, Norbom LB, Doan NT, et al
    Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  69. VEERMAN SR, Schulte PF, Smith JD, de Haan L, et al
    Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  70. CROSSLEY NA, Fox PT, Bullmore ET
    Meta-connectomics: human brain network and connectivity meta-analyses.
    Psychol Med. 2016;46:897-907.
    PubMed     Text format     Abstract available


    March 2016
  71. MORGAN C, John S, Esan O, Hibben M, et al
    The incidence of psychoses in diverse settings, INTREPID (2): a feasibility study in India, Nigeria, and Trinidad.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  72. VAN OMMEN MM, van Beilen M, Cornelissen FW, Smid HG, et al
    The prevalence of visual hallucinations in non-affective psychosis, and the role of perception and attention.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  73. ISING HK, Ruhrmann S, Burger NA, Rietdijk J, et al
    Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  74. WANG Q, Cheng W, Li M, Ren H, et al
    The CHRM3 gene is implicated in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  75. RIGUCCI S, Marques TR, Di Forti M, Taylor H, et al
    Effect of high-potency cannabis on corpus callosum microstructure.
    Psychol Med. 2016;46:841-54.
    PubMed     Text format     Abstract available


    February 2016
  76. FORTGANG RG, Hultman CM, van Erp TG, Cannon TD, et al
    Multidimensional assessment of impulsivity in schizophrenia, bipolar disorder, and major depressive disorder: testing for shared endophenotypes.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


  77. FETT AJ, Shergill SS, Korver-Nieberg N, Yakub F, et al
    Learning to trust: trust and attachment in early psychosis.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    January 2016
  78. PU W, Luo Q, Palaniyappan L, Xue Z, et al
    Failed cooperative, but not competitive, interaction between large-scale brain networks impairs working memory in schizophrenia.
    Psychol Med. 2016.
    PubMed     Text format     Abstract available


    December 2015
  79. BEGEMANN MJ, Daalman K, Heringa SM, Schutte MJ, et al
    Letter to the Editor: Childhood trauma as a risk factor for psychosis: the confounding role of cognitive functioning.
    Psychol Med. 2015.
    PubMed     Text format    


  80. HUI CL, Lee EH, Chang WC, Chan SK, et al
    Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015) - a reply.
    Psychol Med. 2015.
    PubMed     Text format    


  81. PERALTA V, Cuesta MJ
    Letter to the Editor: Comparing delusional disorder and schizophrenia: a comment on Hui et al. (2015).
    Psychol Med. 2015.
    PubMed     Text format    


  82. GERSTENBERG M, Theodoridou A, Traber-Walker N, Franscini M, et al
    Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  83. FONSECA-PEDRERO E, Debbane M, Schneider M, Badoud D, et al
    Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  84. BIANCONI F, Bonomo M, Marconi A, Kolliakou A, et al
    Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  85. BARKER V, Bois C, Johnstone EC, Owens DG, et al
    Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  86. VREEKER A, Boks MP, Abramovic L, Verkooijen S, et al
    High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  87. LEVINE SZ, Levav I, Goldberg Y, Pugachova I, et al
    Exposure to genocide and the risk of schizophrenia: a population-based study.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    November 2015
  88. KRAAN T, Velthorst E, Koenders L, Zwaart K, et al
    Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  89. MCCLEERY A, Green MF, Hellemann GS, Baade LE, et al
    Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
    Psychol Med. 2015.
    PubMed     Text format    


  90. HAUKVIK UK, Hartberg CB, Nerland S, Jorgensen KN, et al
    No progressive brain changes during a 1-year follow-up of patients with first-episode psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    October 2015
  91. SUMNER JA, Duncan L, Ratanatharathorn A, Roberts AL, et al
    Research Letter: PTSD has shared polygenic contributions with bipolar disorder and schizophrenia in women.
    Psychol Med. 2015.
    PubMed     Text format    


  92. LUI SS, Liu AC, Chui WW, Li Z, et al
    The nature of anhedonia and avolition in patients with first-episode schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  93. ALAMEDA L, Ferrari C, Baumann PS, Gholam-Rezaee M, et al
    Childhood sexual and physical abuse: age at exposure modulates impact on functional outcome in early psychosis patients.
    Psychol Med. 2015;45:2727-36.
    PubMed     Text format     Abstract available


  94. ZHENG Y, Wu C, Li J, Wu H, et al
    Brain substrates of perceived spatial separation between speech sources under simulated reverberant listening conditions in schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    September 2015
  95. ALEMANY S, Moya J, Ibanez MI, Villa H, et al
    Research Letter: Childhood trauma and the rs1360780 SNP of FKBP5 gene in psychosis: a replication in two general population samples.
    Psychol Med. 2015.
    PubMed     Text format    


  96. AJNAKINA O, Trotta A, Oakley-Hannibal E, Di Forti M, et al
    Impact of childhood adversities on specific symptom dimensions in first-episode psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  97. APPIAH-KUSI E, Leyden E, Parmar S, Mondelli V, et al
    Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  98. MARTIN AK, Mowry B
    Increased rare duplication burden genomewide in patients with treatment-resistant schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  99. XU T, Wang Y, Li Z, Huang J, et al
    Heritability and familiality of neurological soft signs: evidence from healthy twins, patients with schizophrenia and non-psychotic first-degree relatives.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  100. WHITE TP, Borgan F, Ralley O, Shergill SS, et al
    You looking at me?: Interpreting social cues in schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    August 2015
  101. SCHALLMO MP, Sponheim SR, Olman CA
    Reduced contextual effects on visual contrast perception in schizophrenia and bipolar affective disorder.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  102. EISENACHER S, Rausch F, Ainser F, Mier D, et al
    Investigation of metamemory functioning in the at-risk mental state for psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  103. CULLEN AE, Day FL, Roberts RE, Pariante CM, et al
    Pituitary gland volume and psychosocial stress among children at elevated risk for schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  104. VAN OOSTERHOUT B, Smit F, Krabbendam L, Castelein S, et al
    Metacognitive training for schizophrenia spectrum patients: a meta-analysis on outcome studies.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  105. SODERLUND J, Wicks S, Jorgensen L, Dalman C, et al
    Comparing cohort incidence of schizophrenia with that of bipolar disorder and affective psychosis in individuals born in Stockholm County 1955-1967.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  106. CARRION RE, McLaughlin D, Auther AM, Olsen R, et al
    The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  107. YUNG AR, Cotter J, Wood SJ, McGorry P, et al
    Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  108. MORRISON AP, Shryane N, Fowler D, Birchwood M, et al
    Negative cognition, affect, metacognition and dimensions of paranoia in people at ultra-high risk of psychosis: a multi-level modelling analysis.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  109. SHAH JL, Tandon N, Howard ER, Mermon D, et al
    Pituitary volume and clinical trajectory in young relatives at risk for schizophrenia.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  110. VELING W, Susser E, Selten JP, Hoek HW, et al
    Social disorganization of neighborhoods and incidence of psychotic disorders: a 7-year first-contact incidence study.
    Psychol Med. 2015;45:1789-98.
    PubMed     Text format     Abstract available


    June 2015
  111. BECHI M, Bosia M, Spangaro M, Buonocore M, et al
    Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  112. CORCORAN CM, Keilp JG, Kayser J, Klim C, et al
    Emotion recognition deficits as predictors of transition in individuals at clinical high risk for schizophrenia: a neurodevelopmental perspective.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  113. HUI CL, Lee EH, Chang WC, Chan SK, et al
    Delusional disorder and schizophrenia: a comparison of the neurocognitive and clinical characteristics in first-episode patients.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


    May 2015
  114. ROIZ-SANTIANEZ R, Ortiz-Garcia de la Foz V, Ayesa-Arriola R, Tordesillas-Gutierrez D, et al
    No progression of the alterations in the cortical thickness of individuals with schizophrenia-spectrum disorder: a three-year longitudinal magnetic resonance imaging study of first-episode patients.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  115. OLIVIER MR, Killian S, Chiliza B, Asmal L, et al
    Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  116. DE MENIL V, Knapp M, McDaid D, Raja S, et al
    Cost-effectiveness of the Mental Health and Development model for schizophrenia-spectrum and bipolar disorders in rural Kenya.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  117. SMEERDIJK M, Keet R, van Raaij B, Koeter M, et al
    Motivational interviewing and interaction skills training for parents of young adults with recent-onset schizophrenia and co-occurring cannabis use: 15-month follow-up.
    Psychol Med. 2015.
    PubMed     Text format     Abstract available


  118. WICKHAM S, Sitko K, Bentall RP
    Insecure attachment is associated with paranoia but not hallucinations in psychotic patients: the mediating role of negative self-esteem.
    Psychol Med. 2015;45:1495-507.
    PubMed     Text format     Abstract available


    April 2015
  119. VELIKONJA T, Fisher HL, Mason O, Johnson S, et al
    Childhood trauma and schizotypy: a systematic literature review.
    Psychol Med. 2015;45:947-63.
    PubMed     Text format     Abstract available


  120. FETT AK, Shergill SS, Krabbendam L
    Social neuroscience in psychiatry: unravelling the neural mechanisms of social dysfunction.
    Psychol Med. 2015;45:1145-65.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: